140 related articles for article (PubMed ID: 25923493)
1. [The treatment of locally recurrent rectal cancer].
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; Burger JW
Ned Tijdschr Geneeskd; 2015; 159():A8199. PubMed ID: 25923493
[TBL] [Abstract][Full Text] [Related]
2. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
[TBL] [Abstract][Full Text] [Related]
3. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of chemoradiotherapy for the treatment of rectal cancer].
Koda K; Miyazaki M
Gan To Kagaku Ryoho; 2002 May; 29(5):703-8. PubMed ID: 12040673
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia.
Hildebrandt B; Wust P; Gellermann J; Nicolaou A; Trappe RU; Felix R; Riess H; Rau B
Onkologie; 2004 Oct; 27(5):506-11. PubMed ID: 15585984
[TBL] [Abstract][Full Text] [Related]
7. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease.
Kishan AU; Voog JC; Wiseman J; Cook RR; Ancukiewicz M; Lee P; Ryan DP; Clark JW; Berger DL; Cusack JC; Wo JY; Hong TS
Br J Radiol; 2017 Aug; 90(1076):20170134. PubMed ID: 28613934
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
[TBL] [Abstract][Full Text] [Related]
10. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
11. Use of brachytherapy in management of locally recurrent rectal cancer.
Goes RN; Beart RW; Simons AJ; Gunderson LL; Grado G; Streeter O
Dis Colon Rectum; 1997 Oct; 40(10):1177-9. PubMed ID: 9336112
[TBL] [Abstract][Full Text] [Related]
12. Pain and quality of life after treatment in patients with locally recurrent rectal cancer.
Esnaola NF; Cantor SB; Johnson ML; Mirza AN; Miller AR; Curley SA; Crane CH; Cleeland CS; Janjan NA; Skibber JM
J Clin Oncol; 2002 Nov; 20(21):4361-7. PubMed ID: 12409336
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
[TBL] [Abstract][Full Text] [Related]
14. Locally recurrent rectal cancer in Norway.
Hansen MH; Balteskard L; Dørum LM; Eriksen MT; Vonen B;
Br J Surg; 2009 Oct; 96(10):1176-82. PubMed ID: 19787766
[TBL] [Abstract][Full Text] [Related]
15. Curative potential of multimodality therapy for locally recurrent rectal cancer.
Hahnloser D; Nelson H; Gunderson LL; Hassan I; Haddock MG; O'Connell MJ; Cha S; Sargent DJ; Horgan A
Ann Surg; 2003 Apr; 237(4):502-8. PubMed ID: 12677146
[TBL] [Abstract][Full Text] [Related]
16. Current management of locally recurrent rectal cancer.
Nielsen MB; Laurberg S; Holm T
Colorectal Dis; 2011 Jul; 13(7):732-42. PubMed ID: 20041928
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
Elliot AH; Othman BN; Suzuki C; Blomqvist L; Martling A; Johansson H; Glimelius B; Nilsson PJ; Iversen H
Anticancer Res; 2021 May; 41(5):2459-2465. PubMed ID: 33952471
[TBL] [Abstract][Full Text] [Related]
18. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
[TBL] [Abstract][Full Text] [Related]
19. Aggressive multimodality treatment for locally advanced irresectable rectal cancer.
Farouk R; Nelson H; Gunderson LL
Br J Surg; 1997 Jun; 84(6):741-9. PubMed ID: 9189078
[TBL] [Abstract][Full Text] [Related]
20. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
